In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002245:Carbon Dioxide / Q000378:metabolism; D002250:Carbon Radioisotopes; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006019:Glycolysis / Q000187:drug effects; D006358:Hot Temperature; D007930:Leucine / Q000378:metabolism; D008698:Mesylates / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014529:Uridine / Q000378:metabolism; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D008698:Mesylates; D002245:Carbon Dioxide; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D007930:Leucine; D005472:Fluorouracil; D013936:Thymidine; D014529:Uridine